Bonn starts new health projects with millions of millions!

Bonn starts new health projects with millions of millions!

On January 29, 2025, the GO-BIO initial support took place in Bonn, in which representatives of the funded research projects and consultants from the University of Bonn and the University Hospital Bonn (UKB) came together. As part of this new funding initiative of the Federal Ministry of Education and Research (BMBF), a total of seven innovative projects from Bonn are financially supported. Each of these projects receives up to 100,000 euros in the exploratory phase in order to further develop and promote life -scientific research approaches. The funding is aimed at ideas that are still in an early stage and are without concrete implementation plans. The focus is on the transfer of promising research results in economic application.

The funded projects cover a wide range of medical challenges. One of these projects, the "Cervixtest" project, focuses on improving the diagnostic test system for cervical cancer. Another project, "Coldex", develops a nasal spray to activate the antiviral immune system. The projects "Epither" and "Pearnet" deal with epilepsy. "Epither" strives for the development of new active ingredients to avoid resistance to anti-epileptic drugs, while "Pearnet" is researching a body sensor network to monitor epilepsy patients. In addition, the “Cure4hair” project is working on improved treatment approaches for hair loss, and the “Reretetina” project is dedicated to the production of human visual cells to research retinal diseases. Furthermore, the "Gestalt Matcher" project works on the development of a AI that is able to recognize rare genetic diseases based on portrait images.

additional funded projects

Another funded project is "Bone2Genene". Artificial intelligence is used here to diagnose bone diseases. The management is responsible for Prof. Dr. Peter Krawitz at the Institute for Genomic Statistics and Bioinformatics of the UKB, which develops software with a team, interpreted medical image data and classifies genetic diseases. Finally, the “Combinatory Asthma Endotyping Assay” project aims to develop a test platform that helps doctors select suitable antibody therapies for severe asthma. This project is made by PD Dr. Gudrun Ulrich-Painich.

digitization and future prospects

The GO-BIO Initial is not only an important step for the relevant research, but is also in the context of increasing digitization in healthcare. The use of intelligent programs for the analysis of medical image data and to support the diagnoses and therapy planning shows how important artificial intelligence (AI) has become in this area. Germany strives to become a pioneer in the field of digital health innovations and has created a comprehensive roadmap for this.

The Federal Government has also devoted itself to the challenge of ensuring data protection and data security in dealing with sensitive health data. The focus is not only on the development of new methods for the analysis of complex data, but also on the networking of German university clinics and partners to improve patient care. Electronic patient files should be available at all German university clinics by 2025 in order to optimize health care through faster diagnoses and avoiding double examinations.

Overall, the GO-BIO Initial support shows how important the combination of research and practical application is and how new technologies can help to further develop medicine. With a clear focus on innovation and cooperation, the path is paved into an improved health system.

For detailed information on funding and the projects, visit the pages of Kabinett Online , University Bonn and Health Research BMBF .